208 related articles for article (PubMed ID: 3118717)
21. The morphologic response of the human endometrium to long-term treatment with progestational agents.
Ludwig H
Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):796-808. PubMed ID: 7065058
[TBL] [Abstract][Full Text] [Related]
22. Clinical use of oestrogens and progestogens.
Lauritzen C
Maturitas; 1990 Sep; 12(3):199-214. PubMed ID: 2215269
[TBL] [Abstract][Full Text] [Related]
23. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
Cianci A; De Leo V
Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
[TBL] [Abstract][Full Text] [Related]
24. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial.
Notelovitz M; Kitchens CS; Khan FY
Am J Obstet Gynecol; 1992 Nov; 167(5):1255-61. PubMed ID: 1442974
[TBL] [Abstract][Full Text] [Related]
25. Effect of the combined steroidal contraceptives (Gynanovlar 21 and Lyndiol 2.5) on the human adrenocortical and ovarian activities.
Zaki K; Kamal I; Talaat MM; Rashad S; Nour H
Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):41-65. PubMed ID: 12256027
[TBL] [Abstract][Full Text] [Related]
26. Endometrial effects of levonorgestrel and estradiol: A Scanning electron microscopic study of the luminal epithelium.
Nilsson O; Englund D; Weiner E; Victor A
Contraception; 1980 Jul; 22(1):71-83. PubMed ID: 6774851
[TBL] [Abstract][Full Text] [Related]
27. Endometrial histology and biochemistry in climacteric women during oestrogen and oestrogen/progestogen therapy.
Whitehead MI; King RJ; McQueen J; Campbell S
J R Soc Med; 1979 May; 72(5):322-7. PubMed ID: 552525
[TBL] [Abstract][Full Text] [Related]
28. [The triphasic pill].
Belaisch J
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):368-72. PubMed ID: 12280209
[TBL] [Abstract][Full Text] [Related]
29. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
[TBL] [Abstract][Full Text] [Related]
30. Potency of progestogens in oral contraceptives--further delay of menses data.
Swyer GI
Contraception; 1982 Jul; 26(1):23-7. PubMed ID: 7128131
[TBL] [Abstract][Full Text] [Related]
31. [Influence of progestins on adverse effects of oral contraceptives].
Wynn V
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the clinical performance of three triphasic oral contraceptives: a multicenter, randomized comparative trial.
Schilling LH; Bolding OT; Chenault CB; Chong AP; Fleury F; Forrest K; Glick HI; Hasson HM; Heil CG; London RS
Am J Obstet Gynecol; 1989 May; 160(5 Pt 2):1264-8. PubMed ID: 2655451
[TBL] [Abstract][Full Text] [Related]
33. Metabolic effects of two low-dose triphasic oral contraceptives containing ethinyl estradiol and levonorgestrel or gestodene.
Lepot MR; Gaspard UJ
Int J Fertil; 1987; 32 Suppl():15-20. PubMed ID: 2906343
[TBL] [Abstract][Full Text] [Related]
34. Lipid and lipoprotein changes in women taking low-dose, triphasic oral contraceptives: a controlled, comparative, 12-month clinical trial.
Notelovitz M; Feldman EB; Gillespy M; Gudat J
Am J Obstet Gynecol; 1989 May; 160(5 Pt 2):1269-80. PubMed ID: 2655452
[TBL] [Abstract][Full Text] [Related]
35. The clinical and biochemical effects of two combination oral contraceptive agents.
Sapire KE; Berger GM; Maritz JS
S Afr Med J; 1991 Apr; 79(7):376-9. PubMed ID: 1826569
[TBL] [Abstract][Full Text] [Related]
36. Gestodene. A review of its pharmacology, efficacy and tolerability in combined contraceptive preparations.
Wilde MI; Balfour JA
Drugs; 1995 Aug; 50(2):364-95. PubMed ID: 8521763
[TBL] [Abstract][Full Text] [Related]
37. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ
Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516
[TBL] [Abstract][Full Text] [Related]
38. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
[TBL] [Abstract][Full Text] [Related]
39. Comparative studies of 30 micrograms ethinyl estradiol combined with gestodene and desogestrel on blood coagulation, fibrinolysis, and platelets.
Daly L; Bonnar J
Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):430-7. PubMed ID: 2142580
[TBL] [Abstract][Full Text] [Related]
40. Effects of different progestogens on lipoproteins during postmenopausal replacement therapy.
Hirvonen E; Mälkönen M; Manninen V
N Engl J Med; 1981 Mar; 304(10):560-3. PubMed ID: 7453723
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]